Breast Cancer Metastasis Gene Identified
A gene associated with poor-prognosis breast cancer has been identified by genomic profiling studies that may point to a new therapeutic target, investigators here reported.
A gene associated with poor-prognosis breast cancer has been identified by genomic profiling studies that may point to a new therapeutic target, investigators here reported.
The diabetes drug metformin — commonly a first choice for controlling blood sugar in people with type 2 diabetes — is sparking new interest as a cancer fighter.